Rhodium–Rhenium Alloy Nanozymes for Non-inflammatory Photothermal Therapy
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c02550 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Hongna Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, People's Republic of China. Hauptthemen laut MEDLINE: Rhodium, Alloys, Mice, Inbred BALB C, Photothermal Therapy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Hefei National Research Center for Physical Sciences at the Microscale, Key Laboratory of Antiinflammatory and Immune Medicine, Ministry of Education.
Abstract (Originalsprache)
Analogous to thermal ablation techniques in clinical settings, cell necrosis induced during tumor photothermal therapy (PTT) can provoke an inflammatory response that is detrimental to the treatment of tumors. In this study, we employed a straightforward one-step liquid-phase reduction process to synthesize uniform RhRe nanozymes with an average hydrodynamic size of 41.7 nm for non-inflammatory photothermal therapy. The obtained RhRe nanozymes showed efficient near-infrared (NIR) light absorption for effective PTT, coupled with a remarkable capability to scavenge reactive oxygen species (ROS) for anti-inflammatory treatment. After laser irradiation, the 4T1 tumors were effectively ablated without obvious tumor recurrence within 14 days, along with no obvious increase in pro-inflammatory cytokine levels. Notably, these RhRe nanozymes demonstrated high biocompatibility with normal cells and tissues, both in vitro and in vivo, as evidenced by the lack of significant toxicity in female BALB/c mice treated with 10 mg/kg of RhRe nanozymes over a 14 day period. This research highlights RhRe alloy nanoparticles as bioactive nanozymes for non-inflammatory PTT in tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230009, People's Republic of China.
- Hefei National Research Center for Physical Sciences at the Microscale, University of Science and Technology of China, Hefei, Anhui 230026, People's Republic of China.
- Department of Radiation Oncology, The First Affiliated Hospital of USTC West District, Anhui Provincial Cancer Hospital, Hefei, Anhui 230031, People's Republic of China.
- Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Medical University, Hefei, Anhui 230032, People's Republic of China.
ORCID-Profile: Zhaohua Miao, Zhengbao Zha
Förderung
- Hefei National Research Center for Physical Sciences at the Microscale
- Key Laboratory of Antiinflammatory and Immune Medicine, Ministry of Education
Zitieren
APA
Ma, H., Lu, C., Jin, Z., Liu, R., Miao, Z., Zha, Z., & Tao, Z. (2024). Rhodium–Rhenium Alloy Nanozymes for Non-inflammatory Photothermal Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c02550
Vancouver
Ma H, Lu C, Jin Z, Liu R, Miao Z, Zha Z, et al. Rhodium–Rhenium Alloy Nanozymes for Non-inflammatory Photothermal Therapy. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c02550
BibTeX
@article{Ma2024,
author = {Ma, Hongna and Lu, Chenxin and Jin, Zhaoying and Liu, Rui and Miao, Zhaohua and Zha, Zhengbao and Tao, Zhenchao},
title = {Rhodium–Rhenium Alloy Nanozymes for Non-inflammatory Photothermal Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c02550}
}
EUVIMED